C-Kit receptor signaling regulates islet vasculature, β-cell survival, and function in vivo

Diabetes

Volumn 64, Issue 11, 2015, Pages 3852-3866

  Feng, Zhi Chao ^a   Popell, Alex ^a   Li, Jinming ^a   Silverstein, Jenna ^a   Oakie, Amanda ^a   Yee, Siu Pok ^b   Wang, Rennian ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN; PROTEIN KINASE B; RECOMBINANT STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR RELA; VASCULOTROPIN A;

AGED; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATIONAL STUDY; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INS 1 CELL LINE; LIPID DIET; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VASCULAR REMODELING; VASCULARIZATION; ANIMAL; CELL LINE; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; INFLAMMATION; INSULIN-SECRETING CELLS; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-KIT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84956577270     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-0054     Document Type: Article

References (45)

1. Feng Z-C, Riopel M, Popell A, Wang R. A survival kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase. Diabetologia 2015;58:654-665
2. Oberg C, Waltenberger J, Claesson-Welsh L, Welsh M. Expression of protein tyrosine kinases in islet cells: possible role of the Flk-1 receptor for beta-cell maturation from duct cells. Growth Factors 1994;10:115-126
3. Oberg-Welsh C, Welsh M. Effects of certain growth factors on in vitro maturation of rat fetal islet-like structures. Pancreas 1996;12:334-339
4. Welsh M, Annerén C, Lindholm C, Kriz V, Oberg-Welsh C. Role of tyrosine kinase signaling for beta-cell replication and survival. Ups J Med Sci 2000;105:7-15
5. Rachdi L, El Ghazi L, Bernex F, Panthier JJ, Czernichow P, Scharfmann R. Expression of the receptor tyrosine kinase KIT in mature b-cells and in the pancreas in development. Diabetes 2001;50:2021-2028
6. Krishnamurthy M, Ayazi F, Li J, et al. c-Kit in early onset of diabetes: a morphological and functional analysis of pancreatic beta-cells in c-KitW-v mutant mice. Endocrinology 2007;148:5520-5530
7. Wv/+ male mice. Lab Invest 2012;92:543-555
8. Feng Z-C, Riopel M, Li J, Donnelly L, Wang R. Downregulation of Fas activity rescues early onset of diabetes in c-Kit (Wv/+) mice. Am J Physiol Endocrinol Metab 2013;304:E557-E565
9. Feng ZC, Li J, Turco BA, Riopel M, Yee SP, Wang R. Critical role of c-Kit in beta cell function: increased insulin secretion and protection against diabetes in a mouse model. Diabetologia 2012;55:2214-2225
10. Beppu K, Jaboine J, Merchant MS, Mackall CL, Thiele CJ. Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression. J Natl Cancer Inst 2004;96:46-55
11. Litz J, Sakuntala Warshamana-Greene G, Sulanke G, Lipson KE, Krystal GW. The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression. Lung Cancer 2004;46:283-291
12. Litz J, Krystal GW. Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells. Mol Cancer Ther 2006;5:1415-1422
13. + stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. Am J Physiol Heart Circ Physiol 2003;285:H931-H937
14. + cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006;116:1865-1877
15. Lammert E, Cleaver O, Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science 2001;294:564-567
16. Lammert E, Gu G, McLaughlin M, et al. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 2003;13:1070-1074
17. Lai Y, Schneider D, Kidszun A, et al. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation 2005;79:1530-1536
18. Brissova M, Shostak A, Shiota M, et al. Pancreatic islet production of vascular endothelial growth factor-A is essential for islet vascularization, revascularization, and function. Diabetes 2006;55:2974-2985
19. Iwashita N, Uchida T, Choi JB, et al. Impaired insulin secretion in vivo but enhanced insulin secretion from isolated islets in pancreatic beta cell-specific vascular endothelial growth factor-A knock-out mice. Diabetologia 2007;50:380-389
20. Agudo J, Ayuso E, Jimenez V, et al. Vascular endothelial growth factor-mediated islet hypervascularization and inflammation contribute to progressive reduction of b-cell mass. Diabetes 2012;61:2851-2861
21. Dai C, Brissova M, Reinert RB, et al. Pancreatic islet vasculature adapts to insulin resistance through dilation and not angiogenesis. Diabetes 2013;62:4144-4153
22. Ullsten S, Lau J, Carlsson P-O. Vascular heterogeneity between native rat pancreatic islets is responsible for differences in survival and revascularisation post transplantation. Diabetologia 2015;58:132-139
23. Yashpal NK, Li J, Wang R. Characterization of c-Kit and nestin expression during islet cell development in the prenatal and postnatal rat pancreas. Dev Dyn 2004;229:813-825
24. Li J, Quirt J, Do HQ, et al. Expression of c-Kit receptor tyrosine kinase and effect on beta-cell development in the human fetal pancreas. Am J Physiol Endocrinol Metab 2007;293:E475-E483
25. Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP-Y, Baldwin AS. Aktdependent regulation of NF-kappaB is controlled by mTOR and Raptor in association with IKK. Genes Dev 2008;22:1490-1500
26. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1beta-mediated upregulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003;17:2115-2117
27. Ahmed M, Kundu GC. Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells. Mol Cancer 2010;9:101
28. Figueroa YG, Chan AK, Ibrahim R, et al. NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. Exp Hematol 2002;30:1419-1427
29. Ramanathan M, Pinhal-Enfield G, Hao I, Leibovich SJ. Synergistic upregulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter. Mol Biol Cell 2007;18:14-23
30. Konstantinova I, Lammert E. Microvascular development: learning from pancreatic islets. Bioessays 2004;26:1069-1075
31. Richards OC, Raines SM, Attie AD. The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action. Endocr Rev 2010;31:343-363
32. Cai Q, Brissova M, Reinert RB, et al. Enhanced expression of VEGF-A in b cells increases endothelial cell number but impairs islet morphogenesis and b cell proliferation. Dev Biol 2012;367:40-54
33. Brissova M, Aamodt K, Brahmachary P, et al. Islet microenvironment, modulated by vascular endothelial growth factor-A signaling, promotes β cell regeneration. Cell Metab 2014;19:498-511
34. Donath MY, Størling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T. Cytokines and beta-cell biology: from concept to clinical translation. Endocr Rev 2008;29:334-350
35. Nguyen MTA, Favelyukis S, Nguyen A-K, et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 2007;282:35279-35292
36. Ehses JA, Perren A, Eppler E, et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 2007;56:2356-2370
37. Li X, Zhang L, Meshinchi S, et al. Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes. Diabetes 2006;55:2965-2973
38. Tetè S, Tripodi D, Rosati M, et al. Endothelial cells, cholesterol, cytokines, and aging. Int J Immunopathol Pharmacol 2012;25:355-363
39. Rogers GJ, Hodgkin MN, Squires PE. E-cadherin and cell adhesion: a role in architecture and function in the pancreatic islet. Cell Physiol Biochem 2007;20:987-994
40. Yamagata K, Nammo T, Moriwaki M, et al. Overexpression of dominantnegative mutant hepatocyte nuclear factor-1 α in pancreatic b-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced b-cell proliferation, and diabetes. Diabetes 2002;51:114-123
41. Jaques F, Jousset H, Tomas A, et al. Dual effect of cell-cell contact disruption on cytosolic calcium and insulin secretion. Endocrinology 2008;149:2494-2505
42. Wakae-Takada N, Xuan S, Watanabe K, Meda P, Leibel RL. Molecular basis for the regulation of islet beta cell mass in mice: the role of E-cadherin. Diabetologia 2013;56:856-866
43. Smyth D, Leung G, Fernando M, McKay DM. Reduced surface expression of epithelial E-cadherin evoked by interferon-gamma is Fyn kinase-dependent. PLoS One 2012;7:e38441
44. Debelec-Butuner B, Alapinar C, Ertunc N, Gonen-Korkmaz C, Yörükoǧlu K, Korkmaz KS. TNFα-mediated loss of β-catenin/E-cadherin association and subsequent increase in cell migration is partially restored by NKX3.1 expression in prostate cells. PLoS One 2014;9:e109868
45. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-246